Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Allogeneic, Hematopoietic Cell Transplant (HCT)”

118 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 118 results

Testing effectiveness (Phase 2)Study completedNCT00990249
What this trial is testing

Busulfan Plus Clofarabine Followed by Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
LeukemiaLymphomaAllogeneic Haematopoietic Stem Cell Transplantation+1 more
M.D. Anderson Cancer Center 120
Large-scale testing (Phase 3)UnknownNCT01145976
What this trial is testing

Comparison of Cy-Atg vs Flu-Atg for the Conditioning Therapy in Allo-HCT for Adult Aplastic Anemia

Who this might be right for
Aplastic Anemia
Cooperative Study Group A for Hematology 98
Not applicableStudy completedNCT01879072
What this trial is testing

Prospective Cohort for the Evaluation of Biomarkers Following HCT (BMT CTN 1202)

Who this might be right for
Allogeneic Hematopoietic Stem Cell Transplantation
Medical College of Wisconsin 1,860
Testing effectiveness (Phase 2)Looking for participantsNCT06532084
What this trial is testing

Sorafenib Relapase Prophylaxis After HCT With PTBCy Regimen

Who this might be right for
Acute Myeloid Leukemia, in RelapseMyelodysplastic SyndromesChronic Myeloid Leukemia+1 more
St. Petersburg State Pavlov Medical University 88
Not applicableNot Yet RecruitingNCT07717164
What this trial is testing

PRAISE-IR Versus CIBMTR Controls

Who this might be right for
ALL (Acute B-Lymphoblastic Leukemia)AML (Acute Myeloid Leukemia)MDS (Myelodysplastic Syndrome)
Miltenyi Biomedicine GmbH 51
Not applicableStudy completedNCT02194439
What this trial is testing

Bridging Pediatric and Adult Biomarkers in Graft-Versus-Host Disease

Who this might be right for
Graft-Versus-Host Disease
Indiana University 415
Large-scale testing (Phase 3)Looking for participantsNCT07463651
What this trial is testing

MRD-guided Maintenance Post-HCT: Gilteritini vs Sorafenib

Who this might be right for
Acute Myeloid Leukemia (AML)FLT3-ITD MutationAllogeneic Hematopoietic Cell Transplantation (HCT)+3 more
The First Affiliated Hospital of Soochow University 594
Testing effectiveness (Phase 2)Active Not RecruitingNCT04692181
What this trial is testing

SYN-004 Safety and Tolerability in Allo-HCT Subjects

Who this might be right for
Acute Graft-Versus-Host Reaction Following Bone Marrow TransplantPrevention of CDI in Adult Patients Being Treated With IV Beta-lactam Antibiotics
Theriva Biologics, Inc. 36
Not applicableUnknownNCT04724642
What this trial is testing

COVID-19 Vaccine in Patients After Allogeneic HCT, CAR-T Therapy and With Primary Immune Deficiency

Who this might be right for
Allogenic Hematopoietic Cell TransplantCAR-T TherapyPrimary Immunodeficiency
Tel-Aviv Sourasky Medical Center 110
Large-scale testing (Phase 3)Ended earlyNCT00568633
What this trial is testing

Allogeneic HCT Using Nonmyeloablative Host Conditioning With TLI & ATG vs SOC in AML

Who this might be right for
Leukemia, MyeloidLeukemiaAcute Myeloid Leukemia (AML)
Stanford University 58
Not applicableEnded earlyNCT03557749
What this trial is testing

Monitoring of Immune and Microbial Reconstitution in (HCT) and Novel Immunotherapies

Who this might be right for
Immune and Microbial ReconstitutionSystemic Viral InfectionAcute-graft-versus-host Disease+5 more
Masonic Cancer Center, University of Minnesota 210
Early research (Phase 1)Not Yet RecruitingNCT07254793
What this trial is testing

Prophylactic and Therapeutic DLI-X for Leukemia Relapse After HCT

Who this might be right for
Acute Lymphoid LeukemiaAcute Myeloid LeukemiaAcute Undifferentiated Leukemia (AUL)+3 more
University of Arizona 94
Testing effectiveness (Phase 2)Study completedNCT00847639
What this trial is testing

Safety Study of Lenalidomide Maintenance Therapy Post Allogeneic HCT for High-risk Multiple Myeloma

Who this might be right for
Multiple Myeloma
Center for International Blood and Marrow Transplant Research 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT06098313
What this trial is testing

HCT With PTCy in Higher-risk MDS

Who this might be right for
Patients With MDS, Acute Myeloid Leukemia (AML) Evolving From MDS, and Chronic Myelomonocytic Leukemia (CMML)
Asan Medical Center 113
Large-scale testing (Phase 3)Study completedNCT01503515
What this trial is testing

Caspofungin Acetate, Fluconazole, or Voriconazole in Preventing Fungal Infections in Patients Following Donor Stem Cell Transplant

Who this might be right for
Fungal InfectionHematopoietic and Lymphoid Cell Neoplasm
Children's Oncology Group 292
Testing effectiveness (Phase 2)Active Not RecruitingNCT02171104
What this trial is testing

MT2013-31: Allo HCT for Metabolic Disorders and Severe Osteopetrosis

Who this might be right for
Mucopolysaccharidosis DisordersHurler SyndromeHunter Syndrome+26 more
Masonic Cancer Center, University of Minnesota 149
Not applicableStudy completedNCT07155382
What this trial is testing

Allogeneic HCT Using Conditioning Regimen of BuFluATG for AML CR1

Who this might be right for
Acute Myeloid Leukemia (AML)
Asan Medical Center 98
Testing effectiveness (Phase 2)Ended earlyNCT04849910
What this trial is testing

Allogeneic Engineered Hematopoietic Stem Cell Transplant (HCT) Lacking the CD33 Protein, and Post-HCT Treatment With Mylotarg, for Patients With CD33+ AML or MDS

Who this might be right for
Leukemia, Myeloid, AcuteMyelodysplastic Syndromes
Vor Biopharma 67
Testing effectiveness (Phase 2)Ended earlyNCT01044745
What this trial is testing

Rituximab in Preventing Acute Graft-Versus-Host Disease in a Donor Stem Cell Transplant for Hematologic Cancer

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+108 more
University of Nebraska 20
Not applicableNot Yet RecruitingNCT07762508
What this trial is testing

VABu Conditioning Regimen in Allo-HSCT for AML Patients

Who this might be right for
Leukemia, Myeloid, Acute(AML)Hematopoietic Stem Cell Transplantation (HSCT)
The First Affiliated Hospital of Soochow University 42
Next Page